Medication errors in neonates

Theodora A Stavroudis1, Marlene R Miller, Christoph U Lehmann

  • 1Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. tstavro1@jhmi.edu

Clinics in Perinatology
|February 19, 2008
PubMed

Insights

Medication errors in neonatal intensive care units are common but preventable. This review covers error types and strategies to improve patient safety and reduce harm.

Area of Science:

  • Neonatal intensive care
  • Patient safety
  • Medication administration

Background:

  • Medication errors are a significant concern in neonatal care.
  • Preventing harm from medication errors is a national health priority.
  • Neonatal intensive care units (NICUs) experience frequent medication errors.

Purpose of the Study:

  • To review the prevalence and types of medication errors in neonates.
  • To summarize existing strategies for reducing neonatal medication errors.
  • To discuss safety initiatives for minimizing medication errors in the NICU.

Main Methods:

  • Literature review of medication errors in neonatal populations.
  • Analysis of common error types and contributing factors.
  • Synthesis of safety initiatives and error reduction strategies.

Main Results:

  • Medication errors in neonates are common and often avoidable.
  • Various types of medication errors impact neonatal care.
  • Multiple approaches exist to reduce medication errors in the NICU.

Conclusions:

  • Implementing targeted safety initiatives can significantly reduce medication errors.
  • Continuous monitoring and improvement are crucial for neonatal patient safety.
  • Addressing medication errors is essential for preventing harm in neonates.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...